FindTrial
Sign In

The effect of ramosetron on QT interval in children

The effect of ramosetron on QT interval in children

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0000923
Enrollment
44
Registered
2013-11-14
Start date
2014-01-02
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Seoul National University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The pediatric patients who are aged between 3 and 12 years old and scheduled to be recieved intravenous patient-controlled analgesia.

Exclusion criteria

Exclusion criteria: Allergy to opioid and NSAID The risk of malignant hyperthermia Evoked potential monitoring during surgery Electrolyte imbalance and/or hypothyroidism Preoperative QT prolongation Drug taking which affect the QT interval

Design outcomes

Primary

MeasureTime frame
Average QTc changes after ramosetron admisitration during sevoflurane anesthesia—

Secondary

MeasureTime frame
Average changes between basline QTc and QTc during sevoflurane anesthesia—

Countries

Korea, Republic of

Contacts

Public ContactJi-Hyun Lee

Seoul National University Hospital

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026